24 Feb

This past week, I had a case of influenza. It reminded me of an incident many years ago when I began my career as an accountant. I joined the cost accounting department for GD Searle & Co., then an independent, more than one-hundred-year-old, family-controlled public biotechnology company, now a Pfizer subsidiary. The CEO at the time was Daniel Searle, a great-grandson of the founder. Searle was known for releasing the first birth-control pill, Enovid, and for developing Metamucil, Dramamine, Celebrex, and aspartame. The leader of my cost accounting team was Glen, who was in his forties.  Glen had worked for Searle for...